Generic Formulations and API products are listed below.
CONTACT
Group Companies
GENERICS
GENERIC FORMULATIONS
| Sl. No | Molecule Name | Status |
| 1 | Atorvastatin | Commercial (U.S.) |
| 2 | Aminocaproic Acid | Commercial (U.S.) |
| 3 | Dapagliflozin | Tentative Approval (U.S.) |
| 4 | Dasatinib | Approved (Chile) |
| 4 | Dorzolamide | Commercial (U.S.) |
| 5 | Dorzolamide Timolol | Approved (U.S.) |
| 6 | Esomeprazole | Commercial (U.S.) |
| 7 | Everolimus (RLD Affinitor) | Commercial (U.S. & Mexico), Approved (Europe & Saudi Arabia) |
| 8 | Fingolimod (Multiple Sclerosis) | Approved (U.S., Europe, U.K., & UAE) |
| 9 | Labetalol | Commercial (U.S.) |
| 10 | Lenalidomide | Approved (Europe, U.K.) |
| 11 | Mycophenolic Acid | Commercial (U.S.) Approved (Singapore) |
| 11 | Pemetrexed | Tentative Approval (U.S.) |
| 12 | Posaconazole | Commercial (U.S., U.K.) Approved (Europe) |
| 13 | Pravastatin | Commercial (U.S.) |
| 14 | Rosuvastatin | Commercial (U.S., Europe, & Singapore) |
| 15 | Simvastatin | Commercial (U.S.) |
| 16 | Tacrolimus | Commercial (U.S., Mexico, & Singapore) |
| 17 | Teriflunomide | Commercial (U.S.) |
| 18 | Vigabatrin | Approved (U.S.) |
API
| Cardiology | |
| Sl. No | Molecule Name |
| 1 | Simvastatin |
| 2 | Pravastatin |
| 3 | Atorvastatin |
| 4 | Rosuvastatin |
| 5 | Fluvastatin |
| 6 | Dabigatran |
| 7 | Sacubitril/Valsartan |
| 8 | Apixaban |
| 9 | Rivaroxaban |
| Anti-Diabetics | |
| Sl. No | Molecule Name |
| 1 | Vildagliptin |
| 2 | Linagliptin |
| 3 | Sitagliptin (various salts) |
| 4 | Dapagliflozin (different solvate forms) |
| 5 | Empagliflozin |
| 6 | Repaglinide |
| 7 | Liraglutide |
| 8 | Semaglutide |
| Immunosuppressants | |
| Sl. No | Molecule Name |
| 1 | Tacrolimus |
| 2 | Sirolimus |
| 3 | Everolimus |
| 4 | Pimecrolimus |
| 5 | Mycophenolate Mofetil (MMF) |
| 6 | Mycophenolate Sodium (MPS) |
| Multiple Sclerosis | |
| Sl. No | Molecule Name |
| 1 | Glatiramer Acetate |
| 2 | Fingolimod |
| 3 | Teriflunomide |
| Anti-Cancer/Oncology | |
| Sl. No | Molecule Name |
| 1 | Dasatinib |
| 2 | Lenalidomide |
| 3 | Pazopanib |
| 4 | Erdafitinib |
| Other Key Products | |
| Sl. No | Molecule Name |
| 1 | Orlistat |
| 2 | Mirabegron |
| 3 | Posaconazole |
| 4 | Micafungin |
| 5 | Anidulafungin |
| 6 | Brinzolamide |
Know more
about us
KEY MANAGEMENT TEAM
PRESS RELEASES
OUR LEGACY
CORPORATE GOVERNANCE
